Sökning: onr:"swepub:oai:DiVA.org:uu-313411" >
Patient-reported ou...
-
Granström, ThereseHögskolan Dalarna,Uppsala universitet,Klinisk diabetologi och metabolism,Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden,Omvårdnad
(författare)
Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
Elsevier BV,2016
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-313411
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-313411URI
-
https://doi.org/10.1016/j.diabres.2016.09.015DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:du-23260URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:134817462URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Aims: To examine objective visual acuity measured with ETDRS, retinal thickness (OCT), patient reported outcome and describe levels of glycated hemoglobin and its association with the effects on visual acuity in patients treated with anti-VEGF for visual impairment due to diabetic macular edema (DME) during 12 months in a real world setting.Methods: In this cross-sectional study, 58 patients (29 females and 29 males; mean age, 68 years) with type 1 and type 2 diabetes diagnosed with DME were included. Medical data and two questionnaires were collected; an eye-specific (NEI VFQ-25) and a generic health-related quality of life questionnaire (SF-36) were used.Results: The total patient group had significantly improved visual acuity and reduced retinal thickness at 4 months and remains at 12 months follow up. Thirty patients had significantly improved visual acuity, and 27 patients had no improved visual acuity at 12 months. The patients with improved visual acuity had significantly improved scores for NEI VFQ-25 subscales including general health, general vision, near activities, distance activities, and composite score, but no significant changes in scores were found in the group without improvements in visual acuity.Conclusions: Our study revealed that anti-VEGF treatment improved visual acuity and central retinal thickness as well as patient-reported outcome in real world 12 months after treatment start.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Forsman, HenriettaHögskolan Dalarna,Omvårdnad(Swepub:du)hfo
(författare)
-
Olinder, Anna LindholmKarolinska Institutet,Uppsala universitet,Klinisk diabetologi och metabolism,Söder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden.;Söder Sjukhuset, Karolinska Inst, Dept Clin Res & Educ, Stockholm, Sweden.(Swepub:uu)annli614
(författare)
-
Gkretsis, DimitriosDalarna Cty Hosp, Dept Ophthalmol, Falun, Sweden.
(författare)
-
Eriksson, Jan W.Uppsala universitet,Klinisk diabetologi och metabolism(Swepub:uu)janer909
(författare)
-
Granstam, ElisabetUppsala universitet,Centrum för klinisk forskning, Västerås,Vastmanland Cty Hosp, Dept Ophthalmol, Vasteras, Sweden.(Swepub:uu)elisgran
(författare)
-
Leksell, JanethHögskolan Dalarna,Uppsala universitet,Klinisk diabetologi och metabolism,Omvårdnad(Swepub:du)jle
(författare)
-
Uppsala universitetKlinisk diabetologi och metabolism
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Diabetes Research and Clinical Practice: Elsevier BV121, s. 157-1650168-82271872-8227
Internetlänk
Hitta via bibliotek
Till lärosätets databas